Dual Labeling of the CBP/p300 KIX Domain for 19FNMR Leads to Identification of a New Small-Molecule Binding Site

被引:10
|
作者
Gee, Clifford T. [1 ]
Arntson, Keith E. [1 ]
Koleski, Edward J. [1 ]
Staebell, Rachel Lynn [1 ]
Pomerantz, William C. K. [1 ]
机构
[1] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA
基金
美国国家科学基金会;
关键词
allosterism; biomolecular NMR; fluorine; NMR spectroscopy; protein-protein interactions; F-19; NMR-SPECTROSCOPY; OBSERVED FLUORINE NMR; DRUGGABLE HOT-SPOTS; ALLOSTERIC COMMUNICATION; PROTEIN INTERFACES; LIGAND-BINDING; DISCOVERY; PATHWAYS; ACID; CBP;
D O I
10.1002/cbic.201700686
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein-Observed Fluorine NMR (PrOFNMR) spectroscopy is an emerging technique for screening and characterizing small-molecule-protein interactions. The choice of which amino acid to label for PrOFNMR can be critical for analysis. Here we report the first use of a protein containing two different fluoroaromatic amino acids for NMR studies. Using the KIX domain of the CBP/p300 as a model system, we examine ligand binding of several small-molecule compounds elaborated from our previous fragment screen and identify a new ligand binding site distinct from those used by native transcription factors. This site was further supported by computational modeling (FTMap and Schrodinger) and H-1,N-15 HSQC/HMQC NMR spectroscopy. Metabolic labeling with multiple fluorinated amino acids provides useful probes for further studying ligand binding and has led to new insight for allosterically regulating transcription-factor protein interactions with small-molecule ligands.
引用
收藏
页码:963 / 969
页数:7
相关论文
共 16 条
  • [1] Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
    Brennan, P.E. (paul.brennan@sgc.ox.ac.uk), 1600, American Chemical Society (136):
  • [2] Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
    Hay, Duncan A.
    Fedorov, Oleg
    Martin, Sarah
    Singleton, Dean C.
    Tallant, Cynthia
    Wells, Christopher
    Picaud, Sarah
    Philpott, Martin
    Monteiro, Octovia P.
    Rogers, Catherine M.
    Conway, Stuart J.
    Rooney, Timothy P. C.
    Tumber, Anthony
    Yapp, Clarence
    Filippakopoulos, Panagis
    Bunnage, Mark E.
    Mueller, Susanne
    Knapp, Stefan
    Schofield, Christopher J.
    Brennan, Paul E.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (26) : 9308 - 9319
  • [3] A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb
    Joy, Stephen T.
    Henley, Matthew J.
    De Salle, Samantha N.
    Beyersdorf, Matthew S.
    Vock, Isaac W.
    Huldin, Allison J. L.
    Mapp, Anna K.
    Mapp, Anna K. (amapp@umich.edu), 1600, American Chemical Society (143): : 15056 - 15062
  • [4] A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb
    Joy, Stephen T.
    Henley, Matthew J.
    De Salle, Samantha N.
    Beyersdorf, Matthew S.
    Vock, Isaac W.
    Huldin, Allison J. L.
    Mapp, Anna K.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (37) : 15056 - 15062
  • [5] Modulation of Myb using a Potent and Selective Dual-Site Inhibitor of CBP/p300 KIX
    Joy, Stephen
    Henley, Matthew
    Beyersdorf, Matthew
    Valdes, Yanira Rodriguez
    Mapp, Anna
    PROTEIN SCIENCE, 2021, 30 : 139 - 140
  • [6] Effect of Transient Helicity of cMyb TAD on its Binding Affinity to the Kix Domain of CBP/p300
    Poosapati, Anusha
    Borcherds, Wade
    Carbtree, Michael D.
    Shammas, Sarah L.
    Clarke, Jane
    Daughdrill, Gary W.
    FASEB JOURNAL, 2017, 31
  • [7] Targeting oncogenic enhancer activity with a small-molecule CBP/P300 bromodomain inhibitor
    Raisner, Ryan
    Bainer, Russell
    Chan, Emily
    Garcia, Jesse
    Merchant, Mark
    Gascoigne, Karen
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs
    Katavolos, Paula
    Cain, Gary
    Farman, Cindy
    Romero, F. Anthony
    Magnuson, Steven
    Ly, Justin Q.
    Choo, Edna F.
    Katakam, Anand Kumar
    Andaya, Roxanne
    Maher, Jonathan
    TOXICOLOGIC PATHOLOGY, 2020, 48 (03) : 465 - 480
  • [9] Functional redundancy between the transcriptional activation domains of E2A is mediated by binding to the KIX domain of CBP/p300
    Denis, Christopher M.
    Langelaan, David N.
    Kirlin, Alyssa C.
    Chitayat, Seth
    Munro, Kim
    Spencer, Holly L.
    LeBrun, David P.
    Smith, Steven P.
    NUCLEIC ACIDS RESEARCH, 2014, 42 (11) : 7370 - 7382
  • [10] Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
    Bowers, Erin M.
    Yan, Gai
    Mukherjee, Chandrani
    Orry, Andrew
    Wang, Ling
    Holbert, Marc A.
    Crump, Nicholas T.
    Hazzalin, Catherine A.
    Liszczak, Glen
    Yuan, Hua
    Larocca, Cecilia
    Saldanha, S. Adrian
    Abagyan, Ruben
    Sun, Yan
    Meyers, David J.
    Marmorstein, Ronen
    Mahadevan, Louis C.
    Alani, Rhoda M.
    Cole, Philip A.
    CHEMISTRY & BIOLOGY, 2010, 17 (05): : 471 - 482